Nek2C functions as a tumor promoter in human breast tumorigenesis

Liu,Ziyu; Wang,Yahong; Wang,Shuling; Zhang,Jing; Zhang,Fei; Niu,Yun

doi:10.3892/ijmm.2012.1069

Nek2C functions as a tumor promoter in human breast tumorigenesis

Authors:
- Ziyu Liu
- Yahong Wang
- Shuling Wang
- Jing Zhang
- Fei Zhang
- Yun Niu
View Affiliations

Affiliations: Department of Breast Cancer Pathology and Research Laboratory, Key Laboratory of Breast Cancer Prevention and Therapy, Ministry of Education, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, P.R. China, Research Center of Basic Medical Sciences, Key Laboratory of Breast Cancer Prevention and Therapy, Ministry of Education, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, P.R. China
Published online on: July 18, 2012 https://doi.org/10.3892/ijmm.2012.1069
Pages: 775-782

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The serine⁄threonine kinase Nek2 has been proposed as a requirement for the progression of breast cancer. The aim of this study was to investigate the expression of Nek2C, which is a splice variant of Nek2, and the role it plays in the different stages of breast cancer. We investigated the role of Nek2C in the MCF10 breast cancer cell lines, MCF10A, MCF10AT, MCF10DCIS.com and MCF10CA1a, using RNA interference and plasmid transfection, as well as breast tissue samples of normal breast tissue (NBT), atypical ductal hyperplasia (ADH), ductal carcinoma in situ (DCIS) and invasive ductal carcinoma (IDC). We detected the mRNA Nek2C expression levels in the MCF10 cell lines and in human breast samples. Our results revealed that the mRNA expression of Nek2C was significantly upregulated in the MCF10DCIS.com and MCF10CA1a cell lines as well as in human primary breast cancer tissue (DCIS and IDC). As expected, the Nek2C downregulation, using RNA interference, decreased the survival, invasion and migration of MCF10DCIS.com and MCF10CA1a cells. Consistent with these results, the Nek2C upregulation in MCF10A and MCF10AT cells using plasmid transfection increased the survival ability of these cells. Our results also revealed a correlation between Nek2C mRNA expression levels and tumor grade. Taken together, our findings suggest that Nek2C plays a signicficant role in breast cancer development and that Nek2C inhibition may be a useful therapeutic approach to targeting human breast tumors.

View Figures

View References

1.	L FletcherGJ CernigliaEA NiggTJ YendRJ MuschelInhibition of centrosome separation after DNA damage: a role for Nek2Radiat Res162128135200410.1667/RR321115387139
2.	AM FryThe Nek2 protein kinase: a novel regulator of centrosome structureOncogene2161846194200210.1038/sj.onc.120571112214248
3.	MJ O’ConnellMJ KrienT HunterNever say neverThe NIMA-related protein kinases in mitotic control Trends Cell Biol132212282003
4.	AM FryP MeraldiEA NiggA centrosomal function for the human Nek2 protein kinase, a member of the NIMA family of cell cycle regulatorsEMBO J17470481199810.1093/emboj/17.2.4709430639
5.	HQ GuoM GaoJ MaT XiaoLL ZhaoY GaoQJ PanAnalysis of the cellular centrosome in fine-needle aspirations of the breastBreast Cancer Res9R48200710.1186/bcr175217662154
6.	WL LingleWH LutzJN IngleNJ MaihleJL SalisburyCentrosome hypertrophy in human breast tumors: Implications for genomic stability and cell polarityProc Natl Acad Sci USA9529502955199810.1073/pnas.95.6.29509501196
7.	Q LiuY HirohashiX DuMI GreeneQ WangNek2 targets the mitotic checkpoint proteins Mad2 and Cdc20: a mechanism for aneuploidy in cancerExp Mol Pathol88225233201010.1016/j.yexmp.2009.12.00420034488
8.	DG HaywardAM FryNek2 kinase in chromosome instability and cancerCancer Lett237155166200610.1016/j.canlet.2005.06.01716084011
9.	DG HaywardRB ClarkeAJ FaragherMR PillaiIM HaganAM FryThe centrosomal kinase Nek2 displays elevated levels of protein expression in human breast cancerCancer Res6473707376200410.1158/0008-5472.CAN-04-096015492258
10.	S de VosWK HofmannTM GroganGene expression profile of serial samples of transformed B-cell lymphomasLab Invest83271285200312594241
11.	K UtoN NakajoN SagataTwo structural variants of Nek2 kinase, termed Nek2A and Nek2B, are differentially expressed in Xenopus tissues and developmentDev Biol208456464199910.1006/dbio.1999.923110191058
12.	M FardilhaW WuR SaAlternatively spliced protein variants as potential therapeutic targets for male infertility and contraceptionAnn NY Acad Sci1030468478200410.1196/annals.1329.05915659832
13.	MJ WorshamG PalsJP SchoutenF MillerN TiwariR van SpaendonkSR WolmanHigh-resolution mapping of molecular events associated with immortalization, transformation, and progression to breast cancer in the MCF10 modelBreast Cancer Res Treat96177186200610.1007/s10549-005-9077-816319984
14.	A Vazquez-MartinR ColomerJ BrunetR LupuJA MenendezOverexpression of fatty acid synthase gene activates HER1/HER2 tyrosine kinase receptors in human breast epithelial cellsCell Prolif415985200810.1111/j.1365-2184.2007.00498.x18211286
15.	W WuJE BaxterSL WattamAlternative splicing controls nuclear translocation of the cell cycle-regulated Nek2 kinaseJ Biol Chem2822643126440200710.1074/jbc.M70496920017626005
16.	S WangW LiN LiuNek2A contributes to tumorigenic growth and possibly functions as potential therapeutic target for human breast cancerJ Cell Biochem11319041914201210.1002/jcb.2405922234886
17.	SE MoodyD PerezTC PanThe transcriptional repressor Snail promotes mammary tumor recurrenceCancer Cell8197209200510.1016/j.ccr.2005.07.00916169465
18.	CM D’CruzEJ GuntherRB Boxerc-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutationsNat Med7235239200111175856
19.	EJ GuntherSE MoodyGK BelkaImpact of p53 loss on reversal and recurrence of conditional Wnt-induced tumorigenesisGenes Dev17488501200310.1101/gad.105160312600942
20.	TC KaragiannisA El-OstaRNA interference and potential therapeutic applications of short interfering RNAsCancer Gene Ther12787795200510.1038/sj.cgt.770085715891770
21.	PY LuF XieMC WoodleIn vivo application of RNA interference: from functional genomics to therapeuticsAdv Gen54117142200516096010
22.	M Ameyar-ZazouaV GuasconiS Ait-Si-AlisiRNA as a route to new cancer therapiesExpert Opin Biol Ther5221224200510.1517/14712598.5.2.22115757383
23.	L FletcherGJ CernigliaTJ YenRJ MuschelLive cell imaging reveals distinct roles in cell cycle regulation for Nek2A and Nek2BBiochem Biophys Acta17448992200510.1016/j.bbamcr.2005.01.00715950749
24.	Y LouJ YaoA ZereshkiNEK2A interacts with MAD1 and possibly functions as a novel integrator of the spindle checkpoint signalingJ Biol Chem2792004920057200410.1074/jbc.M31420520014978040
25.	J YaoC FuX DingNek2A kinase regulates the localization of numatrin to centrosome in mitosisFEBS Lett575112118200410.1016/j.febslet.2004.08.04715388344
26.	N TsunodaT KokuryoK OdaNek2 as a novel molecular target for the treatment of breast carcinomaCancer Sci100111116200910.1111/j.1349-7006.2008.01007.x19038001
27.	I WestwoodDM ChearyJE BaxterMW RichardsRL van MontfortAM FryR BaylissInsights into the conformational variability and regulation of human Nek2 kinaseJ Mol Biol386476485200910.1016/j.jmb.2008.12.03319124027